Enhanced fenoterol/ipratropium bromide delivery in COPD

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1443, 2004-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease

By Konermann M.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 235-242

Adis International

Access to resources Recommend Favorite

A Review of Ipratropium Bromide/Fenoterol Hydrobromide (Berodual ® ) Delivered Via Respimat ® Soft Mist™ Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Disease

By Frank Kässner  

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1671-1682

Adis International

Access to resources Recommend Favorite

Long-Term Efficacy and Safety of Ipratropium Bromide plus Fenoterol via Respimat ® Soft Mist™ Inhaler (SMI) versus a Pressurised Metered-Dose Inhaler in Asthma

By Vincken W.  

Clinical Drug Investigation, Vol. 24, Iss. 1, 2004-01 ,pp. : 17-28

Adis International

Access to resources Recommend Favorite

Ipratropium bromide use in Australia outside guidelines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ipratropium bromide: Anisocoria in an infant: case report

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite